<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:506cde79-82d1-4147-a989-5b55b4a44efa,g:8b760d00-f52f-4c5f-ad97-b8ec8ee616c4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.flex-pharma.com/role/COVERPAGE" xlink:type="simple" xlink:href="flks-20200630.xsd#COVERPAGE"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/COVERPAGE" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="flks-20200630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_daf1a65d-e798-4be6-83df-ed6ec983e784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_0d042077-2469-4c96-867a-81f331242a20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_daf1a65d-e798-4be6-83df-ed6ec983e784" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_0d042077-2469-4c96-867a-81f331242a20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_49b0064a-8fe3-4c87-b01d-e83bc97a5bcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_daf1a65d-e798-4be6-83df-ed6ec983e784" xlink:to="loc_us-gaap_AccountsPayableCurrent_49b0064a-8fe3-4c87-b01d-e83bc97a5bcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_fd9539dd-a394-4247-89b0-cac428c02c05" xlink:href="flks-20200630.xsd#flks_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_daf1a65d-e798-4be6-83df-ed6ec983e784" xlink:to="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_fd9539dd-a394-4247-89b0-cac428c02c05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_92dace7b-7d5e-47d2-988b-2c67b93b887f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_daf1a65d-e798-4be6-83df-ed6ec983e784" xlink:to="loc_us-gaap_NotesPayableCurrent_92dace7b-7d5e-47d2-988b-2c67b93b887f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_68f8da5e-d1ac-4e14-8e07-dac9a47e9598" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_daf1a65d-e798-4be6-83df-ed6ec983e784" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_68f8da5e-d1ac-4e14-8e07-dac9a47e9598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bc7dc08a-2e05-4e15-9820-448dd5a83949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_224dc192-3584-445f-b460-1e5f0bd7d982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bc7dc08a-2e05-4e15-9820-448dd5a83949" xlink:to="loc_us-gaap_StockholdersEquity_224dc192-3584-445f-b460-1e5f0bd7d982" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ae84e139-24ca-473b-8603-b4bf095c8071" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bc7dc08a-2e05-4e15-9820-448dd5a83949" xlink:to="loc_us-gaap_Liabilities_ae84e139-24ca-473b-8603-b4bf095c8071" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c00b828c-f123-4fed-8337-52f50f0538a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2f9af1cf-468b-4609-9238-30a6b5bf2253" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c00b828c-f123-4fed-8337-52f50f0538a8" xlink:to="loc_us-gaap_AssetsCurrent_2f9af1cf-468b-4609-9238-30a6b5bf2253" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7d9c8735-6b39-40e0-9926-8b2e44428545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c00b828c-f123-4fed-8337-52f50f0538a8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7d9c8735-6b39-40e0-9926-8b2e44428545" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_31d6d045-7254-419c-b49d-fcb83e8d5a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c00b828c-f123-4fed-8337-52f50f0538a8" xlink:to="loc_us-gaap_Goodwill_31d6d045-7254-419c-b49d-fcb83e8d5a0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_89620249-eb82-4652-8f3a-fba6701a23ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c00b828c-f123-4fed-8337-52f50f0538a8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_89620249-eb82-4652-8f3a-fba6701a23ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_787d187c-3d4e-4b91-b67f-527e3d27e9aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_925a6d73-ba0b-49a0-a3ab-3c1f852587cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_787d187c-3d4e-4b91-b67f-527e3d27e9aa" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_925a6d73-ba0b-49a0-a3ab-3c1f852587cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_60662362-bf98-47f2-8cf6-5656cedc14f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_787d187c-3d4e-4b91-b67f-527e3d27e9aa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_60662362-bf98-47f2-8cf6-5656cedc14f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_1882c3d9-0cda-4974-a2c6-2ccfb951f842" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_787d187c-3d4e-4b91-b67f-527e3d27e9aa" xlink:to="loc_us-gaap_ReceivablesNetCurrent_1882c3d9-0cda-4974-a2c6-2ccfb951f842" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e565ee32-17d7-485a-a78d-d29be6b458c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2977bcf0-6160-463e-9b3b-3e581477b556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e565ee32-17d7-485a-a78d-d29be6b458c5" xlink:to="loc_us-gaap_PreferredStockValue_2977bcf0-6160-463e-9b3b-3e581477b556" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6fddb8e5-7c40-4694-bce4-ec5452ed4f26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e565ee32-17d7-485a-a78d-d29be6b458c5" xlink:to="loc_us-gaap_CommonStockValue_6fddb8e5-7c40-4694-bce4-ec5452ed4f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_077933d2-0f43-404b-a1c3-885f5e902c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e565ee32-17d7-485a-a78d-d29be6b458c5" xlink:to="loc_us-gaap_AdditionalPaidInCapital_077933d2-0f43-404b-a1c3-885f5e902c5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cc29619b-119c-4a21-b29e-03cb18259b95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e565ee32-17d7-485a-a78d-d29be6b458c5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cc29619b-119c-4a21-b29e-03cb18259b95" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="simple" xlink:href="flks-20200630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="flks-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6224a55b-e722-4139-82a5-cb9fb9424414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c475cb72-551c-448b-b25d-da9550a37b77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6224a55b-e722-4139-82a5-cb9fb9424414" xlink:to="loc_us-gaap_OperatingIncomeLoss_c475cb72-551c-448b-b25d-da9550a37b77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_94c38be5-a2a9-4472-9f22-62e4d1cbf227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6224a55b-e722-4139-82a5-cb9fb9424414" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_94c38be5-a2a9-4472-9f22-62e4d1cbf227" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_f099ecda-c971-48ff-8634-21deaa1e2dea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6224a55b-e722-4139-82a5-cb9fb9424414" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_f099ecda-c971-48ff-8634-21deaa1e2dea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome_a6718d6b-2d5c-487b-bfc3-fa940a7e0397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6224a55b-e722-4139-82a5-cb9fb9424414" xlink:to="loc_us-gaap_OtherNonoperatingIncome_a6718d6b-2d5c-487b-bfc3-fa940a7e0397" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a63cee7d-9fb3-4a0c-adb8-970247c1cc05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d066f7e5-e471-4f01-a60c-da6707ac6a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a63cee7d-9fb3-4a0c-adb8-970247c1cc05" xlink:to="loc_us-gaap_OperatingExpenses_d066f7e5-e471-4f01-a60c-da6707ac6a24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26ee3f5a-3360-4146-94e3-994501a01abc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a63cee7d-9fb3-4a0c-adb8-970247c1cc05" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26ee3f5a-3360-4146-94e3-994501a01abc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_af6a747b-ad10-49ff-b2f6-f2266beae4b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_951a5572-3b0f-4873-a71e-d91eefa2df1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_af6a747b-ad10-49ff-b2f6-f2266beae4b7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_951a5572-3b0f-4873-a71e-d91eefa2df1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_58220bc8-3130-4c3d-8d05-a4ae17b56915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_af6a747b-ad10-49ff-b2f6-f2266beae4b7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_58220bc8-3130-4c3d-8d05-a4ae17b56915" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="flks-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_49047256-2da0-4dda-a545-86252463dd9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d9d2d09-1989-4d54-8989-17808f073d43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_49047256-2da0-4dda-a545-86252463dd9d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d9d2d09-1989-4d54-8989-17808f073d43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b78ac0a-1e66-4f15-a3e2-555601a0b370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_49047256-2da0-4dda-a545-86252463dd9d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b78ac0a-1e66-4f15-a3e2-555601a0b370" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73109843-f79d-4ba8-8634-9984931c0813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_4d21e7f4-8776-43b5-8766-4dc6b827a1d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73109843-f79d-4ba8-8634-9984931c0813" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_4d21e7f4-8776-43b5-8766-4dc6b827a1d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_7c3ab3de-1d77-4717-8e1e-4f26e90e9893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73109843-f79d-4ba8-8634-9984931c0813" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_7c3ab3de-1d77-4717-8e1e-4f26e90e9893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_ea43ca7d-d2c7-46b2-9464-35f002a49791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73109843-f79d-4ba8-8634-9984931c0813" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_ea43ca7d-d2c7-46b2-9464-35f002a49791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_9b0acbdf-7200-4262-8dd5-a3d5cca27928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73109843-f79d-4ba8-8634-9984931c0813" xlink:to="loc_us-gaap_PaymentsOfDividends_9b0acbdf-7200-4262-8dd5-a3d5cca27928" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19c42840-c31a-4a20-a07c-0c8061669187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6ce613f3-2e7b-4894-92da-4a3e6b1cdf98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19c42840-c31a-4a20-a07c-0c8061669187" xlink:to="loc_us-gaap_ShareBasedCompensation_6ce613f3-2e7b-4894-92da-4a3e6b1cdf98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9577617c-8d2d-4891-bdf8-58de1b28716c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19c42840-c31a-4a20-a07c-0c8061669187" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9577617c-8d2d-4891-bdf8-58de1b28716c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fc0c90bb-14f4-4538-8edd-9a5805e1b89b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19c42840-c31a-4a20-a07c-0c8061669187" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fc0c90bb-14f4-4538-8edd-9a5805e1b89b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b71cd8c0-5016-46c4-ae83-15412ef385f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19c42840-c31a-4a20-a07c-0c8061669187" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b71cd8c0-5016-46c4-ae83-15412ef385f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_1c880e4a-e5cd-4e38-b603-7208a50205a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19c42840-c31a-4a20-a07c-0c8061669187" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_1c880e4a-e5cd-4e38-b603-7208a50205a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueToRelatedParties_b9a1e757-15d9-4b90-bb8f-6fa3699a64ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19c42840-c31a-4a20-a07c-0c8061669187" xlink:to="loc_us-gaap_IncreaseDecreaseInDueToRelatedParties_b9a1e757-15d9-4b90-bb8f-6fa3699a64ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_900d2596-92a6-4530-9773-40acd6ad7fda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19c42840-c31a-4a20-a07c-0c8061669187" xlink:to="loc_us-gaap_NetIncomeLoss_900d2596-92a6-4530-9773-40acd6ad7fda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_128e25b8-cc0b-434b-a364-8d2da1adeb44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19c42840-c31a-4a20-a07c-0c8061669187" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_128e25b8-cc0b-434b-a364-8d2da1adeb44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_920efdcc-8136-4c11-8ec9-a152efd2acd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19c42840-c31a-4a20-a07c-0c8061669187" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_920efdcc-8136-4c11-8ec9-a152efd2acd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_6345c4cd-25c8-4cbf-8db0-1ec0c0175cc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19c42840-c31a-4a20-a07c-0c8061669187" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_6345c4cd-25c8-4cbf-8db0-1ec0c0175cc4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="flks-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/ORGANIZATIONANDOPERATIONS" xlink:type="simple" xlink:href="flks-20200630.xsd#ORGANIZATIONANDOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/ORGANIZATIONANDOPERATIONS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="flks-20200630.xsd#BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="flks-20200630.xsd#BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSAL" xlink:type="simple" xlink:href="flks-20200630.xsd#REVERSEACQUISITIONANDDISPOSAL"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSAL" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALTables" xlink:type="simple" xlink:href="flks-20200630.xsd#REVERSEACQUISITIONANDDISPOSALTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALNarrativeDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#REVERSEACQUISITIONANDDISPOSALNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALSummaryofPurchaseConsiderationDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#REVERSEACQUISITIONANDDISPOSALSummaryofPurchaseConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALSummaryofPurchaseConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ced6e915-03ec-49db-8eff-df7c0562b034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_cd549c03-9424-4b54-b117-56bbb1b37aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ced6e915-03ec-49db-8eff-df7c0562b034" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_cd549c03-9424-4b54-b117-56bbb1b37aa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_BusinessCombinationConsiderationTransferredFairValueOfRightsToWarrants_bb427a1e-cf15-4f8d-ad04-be1c8f8bd9e6" xlink:href="flks-20200630.xsd#flks_BusinessCombinationConsiderationTransferredFairValueOfRightsToWarrants"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ced6e915-03ec-49db-8eff-df7c0562b034" xlink:to="loc_flks_BusinessCombinationConsiderationTransferredFairValueOfRightsToWarrants_bb427a1e-cf15-4f8d-ad04-be1c8f8bd9e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_BusinessCombinationConsiderationTransferredFairValueOfOutstandingOptions_fafb54e5-a4ef-4eb2-afb0-0ba1cec9d052" xlink:href="flks-20200630.xsd#flks_BusinessCombinationConsiderationTransferredFairValueOfOutstandingOptions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ced6e915-03ec-49db-8eff-df7c0562b034" xlink:to="loc_flks_BusinessCombinationConsiderationTransferredFairValueOfOutstandingOptions_fafb54e5-a4ef-4eb2-afb0-0ba1cec9d052" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#REVERSEACQUISITIONANDDISPOSALScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_fab93f53-777a-49e8-a117-0ee419a105db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9c37b716-5d0d-4dd2-beb6-4452d8490c51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_fab93f53-777a-49e8-a117-0ee419a105db" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9c37b716-5d0d-4dd2-beb6-4452d8490c51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_da7d3c54-0b88-44c8-b050-815f07db7420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_fab93f53-777a-49e8-a117-0ee419a105db" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_da7d3c54-0b88-44c8-b050-815f07db7420" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7846fba3-03c4-4a5c-89e1-2e8c92baa080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_eb443b1f-2b48-4695-86b9-086928b11c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7846fba3-03c4-4a5c-89e1-2e8c92baa080" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_eb443b1f-2b48-4695-86b9-086928b11c6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_54f28e3e-5429-4295-b46e-7523cb0d31ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7846fba3-03c4-4a5c-89e1-2e8c92baa080" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_54f28e3e-5429-4295-b46e-7523cb0d31ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_f3c4bfa2-e068-4bdb-b36c-2b0caa1d9362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7846fba3-03c4-4a5c-89e1-2e8c92baa080" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_f3c4bfa2-e068-4bdb-b36c-2b0caa1d9362" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwillAndIntangibleAssets_94a63971-ff16-4087-be3a-333fa9ae61e5" xlink:href="flks-20200630.xsd#flks_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7846fba3-03c4-4a5c-89e1-2e8c92baa080" xlink:to="loc_flks_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwillAndIntangibleAssets_94a63971-ff16-4087-be3a-333fa9ae61e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_469d1ceb-cd19-469e-8231-41e15bbe5e70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7846fba3-03c4-4a5c-89e1-2e8c92baa080" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_469d1ceb-cd19-469e-8231-41e15bbe5e70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_bd4162ad-2312-46c5-a6a1-39438c47920f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_057cdadf-8e59-4200-bba9-fc828fc84d81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_bd4162ad-2312-46c5-a6a1-39438c47920f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_057cdadf-8e59-4200-bba9-fc828fc84d81" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALScheduleofUnauditedProFormaResultsDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#REVERSEACQUISITIONANDDISPOSALScheduleofUnauditedProFormaResultsDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALScheduleofUnauditedProFormaResultsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/GRANTSRECEIVABLE" xlink:type="simple" xlink:href="flks-20200630.xsd#GRANTSRECEIVABLE"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/GRANTSRECEIVABLE" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/GRANTSRECEIVABLEDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#GRANTSRECEIVABLEDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/GRANTSRECEIVABLEDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETS" xlink:type="simple" xlink:href="flks-20200630.xsd#PREPAIDEXPENSESANDOTHERCURRENTASSETS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSTables" xlink:type="simple" xlink:href="flks-20200630.xsd#PREPAIDEXPENSESANDOTHERCURRENTASSETSTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#PREPAIDEXPENSESANDOTHERCURRENTASSETSScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6b50d461-464b-413e-a8bf-8dff6d1e80dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_b7302faf-4645-4334-968c-81deca787c96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6b50d461-464b-413e-a8bf-8dff6d1e80dc" xlink:to="loc_us-gaap_OtherAssetsCurrent_b7302faf-4645-4334-968c-81deca787c96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_PrepaidClinicalTrialExpense_ff4dd90d-b932-412e-942f-0f9a91560942" xlink:href="flks-20200630.xsd#flks_PrepaidClinicalTrialExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6b50d461-464b-413e-a8bf-8dff6d1e80dc" xlink:to="loc_flks_PrepaidClinicalTrialExpense_ff4dd90d-b932-412e-942f-0f9a91560942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_433727b8-8113-4582-a035-0f38d2a57d3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6b50d461-464b-413e-a8bf-8dff6d1e80dc" xlink:to="loc_us-gaap_PrepaidInsurance_433727b8-8113-4582-a035-0f38d2a57d3f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSNarrativeDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#PREPAIDEXPENSESANDOTHERCURRENTASSETSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="flks-20200630.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="flks-20200630.xsd#FAIRVALUEOFFINANCIALINSTRUMENTS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="flks-20200630.xsd#FAIRVALUEOFFINANCIALINSTRUMENTSTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#FAIRVALUEOFFINANCIALINSTRUMENTSDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="flks-20200630.xsd#STOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="flks-20200630.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYScheduleofVariablesusedinBlackScholesModelDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#STOCKHOLDERSEQUITYScheduleofVariablesusedinBlackScholesModelDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYScheduleofVariablesusedinBlackScholesModelDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATION" xlink:type="simple" xlink:href="flks-20200630.xsd#EQUITYBASEDCOMPENSATION"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="flks-20200630.xsd#EQUITYBASEDCOMPENSATIONTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#EQUITYBASEDCOMPENSATIONNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONScheduleofFairValueAssumptionsDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#EQUITYBASEDCOMPENSATIONScheduleofFairValueAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONScheduleofFairValueAssumptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONSummaryofstockoptionactivityDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#EQUITYBASEDCOMPENSATIONSummaryofstockoptionactivityDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONSummaryofstockoptionactivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PAYROLLPROTECTIONPROGRAM" xlink:type="simple" xlink:href="flks-20200630.xsd#PAYROLLPROTECTIONPROGRAM"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PAYROLLPROTECTIONPROGRAM" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PAYROLLPROTECTIONPROGRAMDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#PAYROLLPROTECTIONPROGRAMDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PAYROLLPROTECTIONPROGRAMDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="flks-20200630.xsd#SUBSEQUENTEVENTS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/SUBSEQUENTEVENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="flks-20200630.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended"/>
</link:linkbase>
